← Leaderboards
Gavin Peter Dunn
Massachusetts General Hospital
$4,424,470
Attributed
$5,701,372
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,701,372 · 4
By mechanism
R01$4,824,442 · 3
K08$876,930 · 1
Top collaborators
- Alain Charest3 shared
- Allegra Adele Petti1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- E. Antonio Chiocca$34,514,665
- Gerald P Linette$7,308,810
- Andrew D Luster$52,151,359
- Beth A Costine-Bartell$5,565,588
- David T Scadden$62,181,067
Others in their field
Top investigators on “Tumor Antigens”
- William R Green · Dartmouth College$32,738,211
- John H Sampson · Duke University$30,849,602
- Catherine Ju-Ying Wu · Broad Institute, Inc.$30,485,072
- Elizabeth Marion Jaffee · Johns Hopkins University$26,862,085
- Ian M Thompson · University Of Texas Hlth Sci Ctr San Ant$24,066,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$20,250,477
Research focus
Tumor AntigensImmunobiologyImmunotherapyImmunotherapeutic AgentDendritic CellsCellsTumorMalignant NeoplasmsT-LymphocyteGlioblastomaBrain NeoplasmsGenomicsNeoplastic CellTargeted TreatmentAntigen-Presenting CellsAntigen PresentationNewly DiagnosedPre-Clinical ModelImmunogenicProgramsImmuneTumor ImmunityCancer GenomicsClinical Trials
Grant awards (14)
Engineering T Cell Adoptive Therapy for Glioblastoma$642,482
R01 · FY2025 · NS · contact PI
Unlocking the Immunobiology of Conventional Dendritic Cells to Augment T Cell Activation in Glioblastoma$628,373
R01 · FY2025 · NS · contact PI
Engineering T Cell Adoptive Therapy for Glioblastoma$624,543
R01 · FY2024 · NS · contact PI
Targeting Neoantigens in Glioblastoma$447,405
R01 · FY2024 · NS · contact PI
Engineering T Cell Adoptive Therapy for Glioblastoma$658,407
R01 · FY2023 · NS · contact PI
Targeting Neoantigens in Glioblastoma$482,595
R01 · FY2023 · NS · contact PI
Targeting Neoantigens in Glioblastoma$463,723
R01 · FY2021 · NS · contact PI
Targeting Neoantigens in Glioblastoma$471,961
R01 · FY2020 · NS · contact PI
Targeting Neoantigens in Glioblastoma$404,953
R01 · FY2019 · NS · contact PI
IMMUNOBIOLOGY OF MALIGNANT GLIOMA$177,876
K08 · FY2019 · NS · contact PI
IMMUNOBIOLOGY OF MALIGNANT GLIOMA$177,876
K08 · FY2018 · NS · contact PI
IMMUNOBIOLOGY OF MALIGNANT GLIOMA$177,876
K08 · FY2017 · NS · contact PI
IMMUNOBIOLOGY OF MALIGNANT GLIOMA$171,651
K08 · FY2016 · NS · contact PI
IMMUNOBIOLOGY OF MALIGNANT GLIOMA$171,651
K08 · FY2015 · NS · contact PI